—EMN
— • —
$74.25
P/E
18.14
PEG
—
FCF Yield
—
Rev Growth YoY
-671.0% YoY
Gross Margin
2109.0%
Health Score
4/10
D/E Ratio
0.80
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers in this payload are blank, making a definitive business description impossible from the data alone. Based on available financial ratios — including a Price/Sales of 0.97x and a Price/Book of 1.22x — the company appears to be a relatively asset-light business trading near book value. Without confirmed market cap data, the capitalization tier cannot be determined with certainty.
Financial Health
**Score: 4/10** The margin figures in this dataset are statistically anomalous and warrant extreme caution in interpretation: a reported gross margin of 2,109% and a net margin of 542% are almost certainly the result of data errors, accounting reclassifications, or unusual one-time items rather than genuine operational performance, and cannot be relied upon as indicators of underlying health. On the more credible side, a Debt/Equity ratio of 0.8x is manageable, and a current ratio of 1.37x suggests the company can meet near-term obligations...
Risk Assessment
- **DATA INTEGRITY: Revenue growth of -671% YoY and gross margin of 2,109% are statistically implausible, indicating possible data errors or extreme accounting distortions that make fundamental analysis unreliable.** - **EARNINGS QUALITY: The company beat earnings estimates in only 1 of its last 4 quarters, suggesting persistent shortfalls versus market expectations.** - **CASH FLOW: Free cash flow is unavailable, removing the single most important metric for assessing business sustainability and intrinsic value.** - **TECHNICALS: A confirmed death cross (50-day MA crossing below 200-day MA) is a bearish long-term price signal, compounded by a bearish MACD reading.** - **VALUATION UNCERTAINTY: With no DCF estimate, no PEG ratio, and no TTM Revenue or Net Income figures, there is no reliable framework to establish whether the current price of $74.25 is justified.** ---...